NASDAQ:LONA | Free Cash Flow | LeonaBio, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$20.9M
2025-12-31-$19.4M
2025-03-31-$14.67M
2024-12-31-$26.01M$0.00-$26.01M
2024-03-31-$25.8M$5,000.00-$25.81M
2023-12-31-$26.29M$0.00-$26.29M
2023-03-31-$26.19M$241,000.00-$26.44M
2022-12-31-$15.67M$1,000.00-$15.67M
2022-03-31-$16.57M$745,000.00-$17.32M
2021-12-31-$18.18M$1.03M-$19.2M
2021-03-31-$7.31M$304,000.00-$7.61M
2020-12-31-$10.67M$2.26M-$12.92M
2020-03-31-$1.18M
2019-12-31-$1.03M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$45.73M
2024-12-31-$97.17M$33,000.00-$97.2M
2023-12-31-$100.75M$304,000.00-$101.06M
2022-12-31-$72.47M$1.14M-$73.61M
2021-12-31-$43.1M$1.57M-$44.67M
2020-12-31-$24.11M$2.32M-$26.43M
2019-12-31-$3.71M